Jeffrey Ervin

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.

Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS.

Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS.

Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools.

Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom.

Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.

The Bellevue Hospital provides health care services, contemporary medicine with hometown caring. The firm provides health services include diabetes education, cardiac rehab & cardiac comeback support group, cardiopulmonary care & rehabilitation, centralized scheduling, clyde health clinic, heart failure clinic, home health care, lifeline emergency phone services, northwest Ohio medical equipment company, occupational health center, plastic surgery, Rehabilitation services, and sleep disorders center. The company was founded in 1914 and is headquartered in Bellevue, OH.

First Wave Technologies, Inc. is a medical device company, which develops products for acute care and long-term care markets. The firm focuses on healthcare innovation products. It engages in improving the ease and accuracy of pharmaceutical delivery and providing healthcare experience for both patients and caregivers. The company was founded by Mark S. Dowhy, Bradley P. Fuhrman and Keith Allen Blakely in 2003 and is headquartered in Batavia, NY.

Sapience Therapeutics, Inc. focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Its drug development program involves translating science into novel therapies, and initial goal is to develop a first-in-class treatment for glioblastoma multiforme, which is the most severe and deadly form of brain cancer. The company was founded by Barry Kappel and Isaac Blech in 2015 and is headquartered in Scarsdale, NY.

Employee Benefit Solutions, Inc. provides healthcare cost containment and wellness services. It offers the difference card, an employer-funded debit card programmed for reimbursement of approved out-of-pocket employee healthcare expenditures. The company was founded by Paul Staubi in 2006 and is headquartered in White Plains, NY.

INSPIRIS, Inc. provides healthcare services for elderly people. The company was founded by James A. Deal in 1998 and is headquartered in Hopkins, MN.

LBMC PC operates as an accounting firm. It offers tax planning, general business consulting, information technology development, human resource, staffing, and investment advisory services. The company was founded by David Morgan and Mike Cain in 1984 and is headquartered in Brentwood, TN.

St. Luke's-Roosevelt Hospital Center owns and operates a hospital. It provides services in the areas of emergency, pediatric emergency, pre-hospital care and medical toxicology. The company was founded in 1979 and is headquartered in New York, NY.

VirMedica, Inc. provides technology solutions which designed to optimize the commercialization of specialty pharmaceutical products. It is an innovative holding company bringing together complimentary businesses for the specific purpose of redefining the market access landscape for specialty products. The company’s technology solution offers an end-to-end transformational platform to optimize specialty product commercialization and management. The company was founded by Mark K. Barnes in 2013 and is headquartered in Boston, MA.

Veriskin, Inc. develops and manufactures medical devices for skin cancer diagnostics. The company was founded by Mirianas Chachisvilis, Eugene Tu and Carl Edman and is headquartered in San Diego, CA.

Cohere-Med, Inc. is a healthcare company based in Burlingame, CA that uses data science to optimize clinical outcomes through augmented clinical decision analytics. The private company's solutions include Sepsis Watch, Mortality Model, and Cardiac Decompensation, which accurately predict in-hospital mortality and identify high-risk cardiac decompensation phenotypes via real-time EHR data. Cohere-Med's analytics are successfully delivering care since late 2019 in Duke and other installations, resulting in increased bundle compliance, lower average length of stay, lower mortality, and improved clinical outcomes. The company's analytics stand out from traditional analytics by using a database of millions of clinical parameters of over 42,000 patients at Duke, resulting in true evidence-based medicine.